LARVOL is pleased to present a moderated discussion with top oncologists following AACR's Annual Meeting 2021. In the video below, Dr. Don Dizon and Kinisha Gala discuss the practice-changing impact of AACR presentations in breast cancers.
On April 16, 2021 LARVOL hosted a discussion of the top breast cancer clinical trial abstracts presented during the American Association for Cancer Research (AACR) Annual Meeting 2021, held on April 10-15, 2021. LARVOL's Kinisha Gala interviewed Dr. Don Dizon from Brown University.
The discussion covered AACR abstract #CT026 - A phase II trial of neratinib (NER) or NER plus fulvestrant (FUL) (N+F) in HER2 mutant, non-amplified (HER2mut) metastatic breast cancer (MBC): Part II of MutHER and AACR abstract #CT028 - A pilot study of pembrolizumab and exemestane/leuprolide in premenopausal hormone receptor positive/HER2 negative locally advanced or metastatic breast cancer(PEER).
This discussion highlighted early breast cancer trials and future directions in breast cancer research.
Watch this video for the full discussion:
Our AACR Panel Series covered five therapeutic areas including breast cancer. Click below to read more about them and watch their video analysis.